BioVaxys Technology Corp.
BVAXF · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14,535 | $2,010 | $20,332 | $30,769 |
| - Cash | $212 | $1 | $142 | $593 |
| + Debt | $68 | $0 | $0 | $0 |
| Enterprise Value | $14,391 | $2,009 | $20,190 | $30,176 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | $0 | -$6,418 |
| % Margin | – | – | – | – |
| Net Income | -$3,955 | -$7,687 | -$11,727 | -$6,458 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.202 | -0.573 | -1.2 | -0.779 |
| % Growth | 64.7% | 52.3% | -54% | – |
| Operating Cash Flow | -$1,862 | -$1,055 | -$1,575 | -$5,294 |
| Capital Expenditures | -$1,056 | $0 | $0 | $0 |
| Free Cash Flow | -$2,919 | -$1,055 | -$1,575 | -$5,294 |